- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.11. | Amid Seattle downsizing, Gilead cuts 100+ positions at California HQ | ||
| 18.11. | Cleanup for the IL-23 class in ulcerative colitis as new drugs 'rapidly gained significant momentum': report | ||
| 15.11. | AbbVie doles out awards to support career goals of 20 people living with migraines | ||
| 15.11. | Vaccine stocks sag in US, Europe after RFK Jr.'s HHS appointment | ||
| 15.11. | After US plant reveal, France's Orano Med lays out €250M to build another radioligand facility overseas | ||
| 15.11. | FDA nod for Azurity's Danziten will allow patients to take leukemia med without fasting | ||
| 15.11. | EU regulators endorse meds from BMS, J&J, Eisai and more-plus a clutch of biosims | ||
| 15.11. | Dexcom taps Nick Jonas, other stars for World Diabetes Day push | ||
| 15.11. | Fierce Pharma Asia-Merck and BioNTech's I-O bispecific buys; AstraZeneca CEO's China defense | ||
| 15.11. | With RFK Jr. appointment for HHS, biopharma industry could face powerful adversary in government | ||
| 14.11. | Citing 'capacity constraints,' Novo Nordisk plots global wind-down of human insulin pen production | ||
| 14.11. | EMA changes tack, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population | ||
| 14.11. | PTC wins FDA approval for first brain-delivered gene therapy Kebilidi | ||
| 14.11. | Merck joins American Lung Association in raising awareness of pulmonary arterial hypertension | ||
| 14.11. | FDA slams Merz over 'misleading' Instagram ad for Botox rival | ||
| 14.11. | In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex | ||
| 14.11. | GAO takes FDA to task over lagging plant inspections, recommends action plan | ||
| 14.11. | Otsuka, ICU Medical form joint venture to boost IV solution supply in North America | ||
| 14.11. | Ascend continues to climb with deal that elevates the CDMO's US footprint | ||
| 14.11. | Say goodbye to BeiGene as the oncology biopharma becomes BeOne Medicines in rebrand | ||
| 13.11. | Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 years | ||
| 13.11. | Zimmer gives Schwarzenegger C-suite title for push to terminate immobility | ||
| 13.11. | Marinus cuts 45% of staff as seizure med Ztalmy remains in limbo following phase 3 misses | ||
| 13.11. | After election, FDA's Califf lays out hopes for his Trump-appointed successor | ||
| 13.11. | BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
